CapsoVision, Inc. (CV) Stock Forecast

NASDAQ: CVAnalyst ratings, price target and estimates.

CV analyst forecast

as of October 18, 2026
Analyst consensus
Strong buy
5.00 / 5 from 2 analysts
Price target
$9.50
average of analyst targets
Upside to target
+45.5%
from the latest close
Next earnings
November 12, 2026
EPS estimate $-0.15
52-week range
$4.59 – $14.42

CV analyst ratings

2 analysts
Strong buy
2100%
Buy
00%
Hold
00%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

CV price target

Price $6.53Target $9.50
52-week low $4.5952-week high $14.42

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

CV earnings per share estimates

CapsoVision, Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$0.14−$0.15−$0.14−$0.17+14.7%2
Current fiscal year (2026)−$0.56−$0.56−$0.56−$1.03+45.6%2
Next fiscal year (2027)−$0.44−$0.45−$0.43−$0.56+21.4%2

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

CV revenue estimates

CapsoVision, Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$3.8M$3.7M$3.8M+6.2%2
Current fiscal year (2026)$14.9M$14.8M$14.9M+9.7%2
Next fiscal year (2027)$19.8M$19.7M$19.9M+33.3%2

CV EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

CV revenue: reported and forecast

Reported revenueEstimate (average; low–high)

CV EPS estimate revisions

CapsoVision, Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)−$0.12−$0.12−$0.14−$0.14−$0.14+20.8%0 up · 1 down
Current fiscal year (2026)−$0.52−$0.52−$0.56−$0.56−$0.56+7.7%0 up · 1 down
Next fiscal year (2027)−$0.42−$0.42−$0.44−$0.44−$0.44+4.8%0 up · 1 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

CV earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 6 quarters; CV beat in 1 of 6.

What analysts expect from CV

2 analysts cover CapsoVision; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $9.50, 45.5% above the latest close of $6.53. Analysts expect earnings of −$0.56 per share for 2026, +45.6% from a year earlier. For 2027 the average estimate is −$0.44 per share on revenue of $19.8 million. CapsoVision beat the EPS estimate in 1 of the last 6 quarters.

Related: CV income statement, CV key metrics, CV chart. See the CV stock overview for the latest quote and news.

CV forecast FAQ

What is CapsoVision's price target?

The average analyst price target for CapsoVision is $9.50, 45.5% above the latest close of $6.53.

Is CapsoVision a buy, hold or sell?

Of 2 analysts covering CapsoVision, 2 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.

What is CapsoVision's EPS forecast?

Analysts forecast −$0.56 per share for 2026 (range −$0.56 to −$0.56); for 2027 the estimate is −$0.44.

What is CapsoVision's revenue forecast?

The average revenue estimate for 2026 is $14.9 million, growth of 9.7%; for 2027 it is $19.8 million.

When does CapsoVision report earnings?

CapsoVision is expected to report results for the quarter ending September 30, 2026 on November 12, 2026 after the market closes; the EPS estimate is $-0.15.

Does CapsoVision usually beat earnings estimates?

CapsoVision reported EPS at or above the analyst estimate in 1 of the last 6 quarters.

Medical Devices: forecast